Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine
This study has been completed.
Study NCT00920517   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on June 11, 2009.   Last Updated on December 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Dengue Fever
Additional conditions recognized in this trial
Dengue
Dengue Hemorrhagic Fever
More general conditions related to this trial
Arbovirus Infections
Flaviviridae Infections
Flavivirus Infections
Hemorrhagic Fevers, Viral
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
rDEN2/4delta30(ME) vaccine
Placebo
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services